NCT07713095

Brief Summary

This study tests the feasibility and acceptability of Waning Moon, a culturally tailored menopause health intervention developed in partnership with the Urban Indian Center of Salt Lake (UICSL) for American Indian/Alaska Native (AI/AN) women. Waning Moon is a 4-session integrative medical group visit program delivered by community health workers and prescribing providers. It covers menopause education, complementary health approaches, and community support. Thirty midlife AI/AN women will participate. The study will assess whether the program is feasible to deliver and acceptable to participants and clinical partners.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
23mo left

Started Aug 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

July 20, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

July 14, 2026

Last Update Submit

July 14, 2026

Conditions

Keywords

MenopauseVasomotor SymptomsWomen's HealthAmerican Indian or Alaska NativeHealth Disparities

Outcome Measures

Primary Outcomes (1)

  • Feasibility - Feasibility of Intervention Measure (FIM) scale

    Participant-reported feasibility of the Waning Moon intervention as measured by the Feasibility of Intervention Measure (FIM) scale.

    Baseline (Week 0), post-intervention (Week 4), and 2-month follow-up (Week 12)

Secondary Outcomes (1)

  • Intervention Appropriateness Measure (IAM)

    Baseline (Week 0), post-intervention (Week 4), and 2-month follow-up (Week 12)

Other Outcomes (1)

  • Intervention Fidelity

    Each Waning Moon session (Weeks 1 through 4)

Study Arms (1)

Waning Moon Intervention

EXPERIMENTAL

Four-session integrative medical group visit program delivered by community health workers with prescribing provider involvement. Sessions cover menopause education, complementary health approaches including acupressure, mindfulness, and herbal supplements, and facilitated community discussion. Participants also complete a follow-up visit at 12 weeks.

Behavioral: Waning Moon

Interventions

Waning MoonBEHAVIORAL

Waning Moon is a culturally tailored integrative medical group visit program developed by and for urban American Indian/Alaska Native women experiencing menopause. The program consists of four weekly 90-minute group sessions delivered by trained community health workers, with involvement from prescribing providers. Sessions integrate conventional and complementary menopause education, experiential practices (mindfulness, self-acupressure), and facilitated group discussion. Topics include vasomotor symptoms, insomnia, stress, pain, inflammation, cardiovascular health, and goal setting. Participants are referred to onsite prescribing providers for clinical evaluation and management as indicated.

Also known as: MENOGAP
Waning Moon Intervention

Eligibility Criteria

Age35 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identifies as American Indian or Alaska Native Female, age 35-65 Experiencing menopause-related symptoms (e.g., vasomotor symptoms) Able to attend sessions at UICSL in Salt Lake City, Utah English-speaking

You may not qualify if:

  • Currently enrolled in another menopause intervention study Do not identify as American Indian or Alaska Native Are not experiencing menopause

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Lisa J Associate Professor, College of Nursing, University of Utah

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Four-session integrative medical group visit program covering menopause education, complementary health approaches (acupressure, mindfulness, yoga, herbal supplements), and community support. Delivered by a prescribing provider.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Site Principal Investigator

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 20, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

July 20, 2026

Record last verified: 2026-04